Judith Tam ALK Lung Cancer Research Initiative Honors and Awards

May 17, 2024: ALK Initiative Project 1 Co-Leader Dr. Nathan Merrill promoted to Research Assistant Professor at the University of Michigan.

May 17, 2024: ALK Initiative Clinical Lead Dr. Angel Qin promoted to Clinical Associate Professor at the University of Michigan.

February 17, 2023: Dr. Marisa Aikins is selected as a Cancer Biology NIH-T32 postdoctoral fellow for support of her work on the Judith Tam ALK Lung Cancer Research Initiative.

February 6, 2023: Dr. Angel Qin receives the prestigious University of Michigan Wicha Award for Early-Mid-Career Investigator from the Division of Hematology Oncology.

December 1, 2022: Dr. Angel Qin is one of three recipients to receive the prestigious 2022 ALK Positive/LUNGevity ALK Positive Lung Cancer Research Award.

These grants, totaling $1.75 million, seek to transform ALK-positive lung cancer outcomes into a chronic or curable condition through continued support of translational and clinical trial research. This funded research award will allow Dr. Qin to evaluate a novel drug called gilteritinib as a treatment in patients with ALK-positive NSCLC whose tumors have developed a resistance to lorlatinib.